Journal
CYTOTHERAPY
Volume 7, Issue 4, Pages 368-373Publisher
ELSEVIER SCI LTD
DOI: 10.1080/14653240500238160
Keywords
clinical trial; multipotent stem cells; spinal cord injury; UC blood
Ask authors/readers for more resources
HLA-matched UC blood-derived multipotent stem cells were directly transplanted into the injured spinal cord site of a 37-year-old female patient suffering from spinal cord injury (SPI). In this case, human cord blood (UCB)-derived multipotent stem cells improved sensory perception and movement in the SPI patient's hips and thighs within 41 days of cell transplantation. CT and MRI results also showed regeneration of the spinal cord at the injured site and some of the cauda equina below it. Therefore, it is suggested that UCB multipotent stem cell transplantation could be a good treatment method for SPI patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available